Rubix LS Information

Rubix LS is a clinical research and evidence generation company. We design studies, run trials, and produce real-world evidence using data from the patient populations most underrepresented in today's research. We work across the full development lifecycle with biotech sponsors, pharmaceutical companies, and federal health agencies. Our teams bring scientific depth, operational discipline, and access to patient populations that most organizations can't reach. What we do: Translational Research and Evidence Strategy We help sponsors identify evidence gaps early and build study designs that hold up through regulatory review and payer evaluation. Our work includes feasibility assessments, biomarker strategy, endpoint selection, and integrated evidence plans shaped by data from 25M+ patient records across underserved communities. Therapeutic areas include oncology, rare disease, and infectious disease. Clinical Trial Services Full-service CRO from pre-clinical studies through Phase II, with partnered Phase III/IV support. We handle protocol development, regulatory strategy, site management, patient recruitment, safety monitoring, data management, and biostatistics. Our mobile clinical sites extend trial access to communities that traditional site networks don't reach, supporting 90% retention in hard-to-reach populations. Federal Health and Public Health Research We partner with federal agencies on infectious disease surveillance, biodefense programs, and community health initiatives, bringing the same scientific rigor we apply to commercial programs combined with experience navigating federal contracting and culturally informed engagement strategies. Our research programs draw on 25M+ integrated patient data sets representing communities, geographies, and disease presentations that are systematically absent from standard clinical databases. That data foundation changes what we can measure, who we can study, and how strong the resulting evidence is. rubixls.com